vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.

PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $143.8M, roughly 1.5× COHEN & STEERS, INC.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs 10.9%, a 13.4% gap on every dollar of revenue. On growth, COHEN & STEERS, INC. posted the faster year-over-year revenue change (2.9% vs -5.5%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs -3.8%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

CNS vs PLAB — Head-to-Head

Bigger by revenue
PLAB
PLAB
1.5× larger
PLAB
$210.4M
$143.8M
CNS
Growing faster (revenue YoY)
CNS
CNS
+8.4% gap
CNS
2.9%
-5.5%
PLAB
Higher net margin
CNS
CNS
13.4% more per $
CNS
24.3%
10.9%
PLAB
More free cash flow
PLAB
PLAB
$151.6M more FCF
PLAB
$25.2M
$-126.4M
CNS
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
-3.8%
PLAB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CNS
CNS
PLAB
PLAB
Revenue
$143.8M
$210.4M
Net Profit
$34.9M
$22.9M
Gross Margin
33.7%
Operating Margin
28.0%
22.9%
Net Margin
24.3%
10.9%
Revenue YoY
2.9%
-5.5%
Net Profit YoY
-23.9%
-32.4%
EPS (diluted)
$0.67
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
PLAB
PLAB
Q4 25
$143.8M
Q3 25
$141.7M
$210.4M
Q2 25
$136.1M
$211.0M
Q1 25
$134.5M
$212.1M
Q4 24
$139.8M
$222.6M
Q3 24
$133.2M
$211.0M
Q2 24
$121.7M
$217.0M
Q1 24
$122.7M
$216.3M
Net Profit
CNS
CNS
PLAB
PLAB
Q4 25
$34.9M
Q3 25
$41.7M
$22.9M
Q2 25
$36.8M
$8.9M
Q1 25
$39.8M
$42.9M
Q4 24
$45.8M
$33.9M
Q3 24
$39.7M
$34.4M
Q2 24
$31.8M
$36.3M
Q1 24
$34.0M
$26.2M
Gross Margin
CNS
CNS
PLAB
PLAB
Q4 25
Q3 25
33.7%
Q2 25
36.9%
Q1 25
35.6%
Q4 24
37.0%
Q3 24
35.6%
Q2 24
36.5%
Q1 24
36.6%
Operating Margin
CNS
CNS
PLAB
PLAB
Q4 25
28.0%
Q3 25
34.5%
22.9%
Q2 25
31.8%
26.4%
Q1 25
33.6%
24.6%
Q4 24
35.3%
25.1%
Q3 24
33.7%
24.7%
Q2 24
31.5%
25.8%
Q1 24
32.8%
26.6%
Net Margin
CNS
CNS
PLAB
PLAB
Q4 25
24.3%
Q3 25
29.4%
10.9%
Q2 25
27.1%
4.2%
Q1 25
29.6%
20.2%
Q4 24
32.8%
15.2%
Q3 24
29.8%
16.3%
Q2 24
26.1%
16.7%
Q1 24
27.7%
12.1%
EPS (diluted)
CNS
CNS
PLAB
PLAB
Q4 25
$0.67
Q3 25
$0.81
$0.39
Q2 25
$0.72
$0.15
Q1 25
$0.77
$0.68
Q4 24
$0.89
$0.54
Q3 24
$0.77
$0.55
Q2 24
$0.63
$0.58
Q1 24
$0.68
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
PLAB
PLAB
Cash + ST InvestmentsLiquidity on hand
$145.5M
$575.8M
Total DebtLower is stronger
$16.0K
Stockholders' EquityBook value
$562.0M
$1.1B
Total Assets
$876.7M
$1.8B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
PLAB
PLAB
Q4 25
$145.5M
Q3 25
$98.1M
$575.8M
Q2 25
$95.4M
$558.4M
Q1 25
$65.2M
$642.2M
Q4 24
$183.0M
$640.7M
Q3 24
$106.5M
$606.4M
Q2 24
$122.0M
$559.9M
Q1 24
$99.5M
$521.5M
Total Debt
CNS
CNS
PLAB
PLAB
Q4 25
Q3 25
$16.0K
Q2 25
$19.0K
Q1 25
$21.0K
Q4 24
$25.0K
Q3 24
$28.0K
Q2 24
$2.5M
Q1 24
$2.7M
Stockholders' Equity
CNS
CNS
PLAB
PLAB
Q4 25
$562.0M
Q3 25
$550.3M
$1.1B
Q2 25
$528.5M
$1.1B
Q1 25
$507.7M
$1.1B
Q4 24
$511.7M
$1.1B
Q3 24
$491.0M
$1.1B
Q2 24
$463.2M
$1.0B
Q1 24
$378.9M
$1.0B
Total Assets
CNS
CNS
PLAB
PLAB
Q4 25
$876.7M
Q3 25
$801.6M
$1.8B
Q2 25
$751.0M
$1.7B
Q1 25
$834.9M
$1.7B
Q4 24
$812.4M
$1.7B
Q3 24
$727.8M
$1.6B
Q2 24
$784.1M
$1.6B
Q1 24
$680.7M
$1.6B
Debt / Equity
CNS
CNS
PLAB
PLAB
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
PLAB
PLAB
Operating Cash FlowLast quarter
$-120.4M
$50.1M
Free Cash FlowOCF − Capex
$-126.4M
$25.2M
FCF MarginFCF / Revenue
-87.9%
12.0%
Capex IntensityCapex / Revenue
4.2%
11.8%
Cash ConversionOCF / Net Profit
-3.45×
2.19×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M
$64.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
PLAB
PLAB
Q4 25
$-120.4M
Q3 25
$55.1M
$50.1M
Q2 25
$-67.6M
$31.5M
Q1 25
$-108.9M
$78.5M
Q4 24
$96.7M
$68.4M
Q3 24
$25.6M
$75.1M
Q2 24
$31.4M
$76.5M
Q1 24
$4.9M
$41.5M
Free Cash Flow
CNS
CNS
PLAB
PLAB
Q4 25
$-126.4M
Q3 25
$52.6M
$25.2M
Q2 25
$-69.8M
$-29.1M
Q1 25
$-110.0M
$43.3M
Q4 24
$85.0M
$25.2M
Q3 24
$24.2M
$50.7M
Q2 24
$27.1M
$56.5M
Q1 24
$537.0K
$-1.8M
FCF Margin
CNS
CNS
PLAB
PLAB
Q4 25
-87.9%
Q3 25
37.1%
12.0%
Q2 25
-51.3%
-13.8%
Q1 25
-81.8%
20.4%
Q4 24
60.8%
11.3%
Q3 24
18.2%
24.0%
Q2 24
22.3%
26.0%
Q1 24
0.4%
-0.8%
Capex Intensity
CNS
CNS
PLAB
PLAB
Q4 25
4.2%
Q3 25
1.8%
11.8%
Q2 25
1.6%
28.7%
Q1 25
0.8%
16.6%
Q4 24
8.3%
19.4%
Q3 24
1.1%
11.6%
Q2 24
3.5%
9.2%
Q1 24
3.5%
20.0%
Cash Conversion
CNS
CNS
PLAB
PLAB
Q4 25
-3.45×
Q3 25
1.32×
2.19×
Q2 25
-1.84×
3.55×
Q1 25
-2.74×
1.83×
Q4 24
2.11×
2.02×
Q3 24
0.65×
2.18×
Q2 24
0.99×
2.11×
Q1 24
0.14×
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNS
CNS

Segment breakdown not available.

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

Related Comparisons